Tissue Plasminogen Activator Chromogenic Substrate

CAT:
952-B2012537
Size:
5 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tissue Plasminogen Activator Chromogenic Substrate - image 1

Tissue Plasminogen Activator Chromogenic Substrate

  • Description:

    Tissue Plasminogen Activator Chromogenic Substrate_x000D_ Catalog number: B2012537_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 5 mg_x000D_ Molecular Weight or Concentration: 658.9 g/mol_x000D_ Supplied as: Lyophilized Powder_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: 2-8°C_x000D_ Keywords: PA, tPA_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Matsuo O, Sakai T, Takakura Y, Mihara H. Substrate specificity of tissue plasminogen activator and urokinase as determined with synthetic chromogenic substrates Jpn J Physiol. 1983;33(6):1031-7._x000D_ 2: Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia Am J Obstet Gynecol. 1994 Jul;171(1):178-83._x000D_ 3: Liang JF, Li Y, Yang VC. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation Thromb Res. 2000 Mar 1;97(5):349-58._x000D_ 4: Okada K, Ueshima S, Matsuno H, Nagai N, Kawao N, Tanaka M, Matsuo O. A synthetic peptide derived from staphylokinase enhances plasminogen activation by tissue-type plasminogen activator J Thromb Haemost. 2011 May;9(5):997-1006._x000D_ 5: Kulisek ES, Holm SE, Johnston KH. A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate Anal Biochem. 1989 Feb 15;177(1):78-84._x000D_ 6: Wang-Lee JL, Lenhart JA, Ohleth KM, Ryan PL, Bagnell CA. Regulation of urokinase- and tissue-type plasminogen activator by relaxin in the uterus and cervix of the prepubertal gilt J Reprod Fertil. 1998 Sep;114(1):119-25._x000D_ 7: Zhuang P, Wo D, Xu ZG, Wei W, Mao HM. Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke J Clin Neurosci. 2015 Jul;22(7):1123-7._x000D_ 8: Kuusela P, Ullberg M, Saksela O, Kronvall G. Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci Infect Immun. 1992 Jan;60(1):196-201._x000D_ 9: de Souza LR, M Melo P, Paschoalin T, Carmona AK, Kondo M, Hirata IY, Blaber M, Tersariol I, Takatsuka J, Juliano MA, Juliano L, Gomes RA, Puzer L. Human tissue kallikreins 3 and 5 can act as plasminogen activator releasing active plasmin Biochem Biophys Res Commun. 2013 Apr 12;433(3):333-7._x000D_ 10: Rouy D, Anglés-Cano E. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin Biochem J. 1990 Oct 1;271(1):51-7. _x000D_ _x000D_ Products Related to Tissue Plasminogen Activator Chromogenic Substrate can be found at Substrates
  • Short Description:

    Catalog Number: B2012537 (5 mg)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5
  • Height :

    0.5